SCOLR Pharma, Inc. (AMEX: DDD), a specialty pharmaceutical company, focuses on developing and liscensing Controlled Delivery Technology (CDT®). This technology platform contains multiple patented oral drug delivery technologies for prescription, OTC and nutritional compounds. Through alliances with pharmaceutical and natural products industry companies, SCOLR co-develops new products and adds value as well as protection to existing product franchises. For further information, visit the Company’s web site at www.scolr.com.
- 17 years ago
QualityStocks
SCOLR Pharma, Inc. (AMEX: DDD)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ) Accelerates Upper Kobuk Exploration with Federal Capital Injection
Disseminated on behalf of Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ) and may include paid advertising.…
-
QualityStocksNewsBreaks – Ucore Rare Metals Inc.’s (TSX.V: UCU) (OTCQX: UURAF) RapidSX(TM) Technology Gains Spotlight Amid Global Rare-Earth Shakeup
Disseminated on behalf of Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) and may include paid advertising.…
-
QualityStocksNewsBreaks – Soligenix Inc. (NASDAQ: SNGX) Advancing Heat-Stable Vaccine Platform with New Peer-Reviewed Data
Soligenix (NASDAQ: SNGX) is a late-stage biopharmaceutical company specializing in biodefense and rare disease vaccines. The…